title: Phase III trial begins for elvitegravir.
mesh_terms: D004311:Double-Blind Method; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D015363:Quinolones / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D019428:HIV Integrase Inhibitors; D015363:Quinolones; C509700:elvitegravir